The effect of bradykinin and anti-inflammatory agents on isolated arteries.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000187:drug effects*; D001285:Atropine / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology*; D004336:Drug Antagonism; D004357:Drug Synergism; D004558:Electric Stimulation; D005439:Flufenamic Acid / Q000494:pharmacology; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007609:Kallidin / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008528:Mefenamic Acid / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology*; D011817:Rabbits; D012459:Salicylates / Q000494:pharmacology*; D012701:Serotonin / Q000494:pharmacology; D013618:Tachyphylaxis; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D012459:Salicylates; D014662:Vasoconstrictor Agents; D062367:ortho-Aminobenzoates; D012701:Serotonin; D007609:Kallidin; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D001285:Atropine; D006632:Histamine; D008238:Lysergic Acid Diethylamide; D010653:Phenylbutazone; D000109:Acetylcholine; D001920:Bradykinin; D009638:Norepinephrine; D010646:Phentolamine